tiprankstipranks
Protara Therapeutics, Inc. (TARA)
NASDAQ:TARA
US Market
TARA
Protara Therapeutics
RESEARCH TOOLSreports
Want to see TARA full AI Analyst Report?

Protara Therapeutics (TARA) Income Statement

1,432 Followers

Protara Therapeutics Income Statement

Last quarter (Q1 2026), Protara Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Protara Therapeutics's net income was $-17.78M. See Protara Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -362.00K$ 0.00$ -341.00K$ 0.00$ 0.00
Operating Expenses
$ 64.19M$ 49.15M$ 43.27M$ 67.06M$ 47.49M
Depreciation and Amortization
$ 362.00K$ 332.00K$ 341.00K$ 248.00K$ 117.00K
EBITDA
$ -64.19M$ -48.82M$ -43.27M$ -64.57M$ -45.40M
Operating Income
$ -64.55M$ -49.15M$ -43.61M$ -67.06M$ -47.49M
Other Income/Expenses
$ 7.11M$ 4.56M$ 3.19M$ 1.11M$ 237.00K
Pretax Income
$ -57.44M$ -44.60M$ -40.42M$ -65.95M$ -47.25M
Net Income
$ -57.44M$ -44.60M$ -40.42M$ -65.95M$ -47.25M
Per Share Metrics
Basic EPS
$ -1.34$ -2.17$ -3.57$ -5.86$ -4.20
Diluted EPS
$ -1.34$ -2.17$ -3.57$ -5.86$ -4.20
Weighted Average Shares Outstanding
 42.84M 20.59M 11.33M 11.26M 11.23M
Weighted Average Shares Outstanding (Diluted)
 42.84M 20.59M 11.33M 11.26M 11.23M
Currency in USD

Protara Therapeutics Earnings and Revenue History